PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

$21.02
+0.02 (+0.10%)
As of Apr 1, 3:20 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +29.8% upside
Low Target $18.57
Average Target $27.28
High Target $35.01
Current Price $21.02
Current
$21.02
Target
$27.28
$18.57 $27.28 avg $35.01
Scenario Analysis
Bear Case
$18.57
-11.7%
Low target
Base Case
$27.28
+29.8%
Avg target
Bull Case
$35.01
+66.6%
High target
Risk/Reward
5.7x
Highly favorable
Price in Context
52-Week High
$54.29
-61.3% from high
52-Week Low
$9.00
+133.6% from low
Target vs 52W High
$27.28
-49.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%